PubMed Health⌕ Search

Biomedical subjects

J P Shoemaker

Publications and source records attributed to J P Shoemaker.

16 recordsLinked to original sources

Treatment for AIDS and other retrovirus-caused diseases.

The role of retroviruses as causal agents in animal and human neoplasms is reviewed. Based on previous studies done on retrovirus caused mouse mammary adenocarcinoma, it is suggested that a treatment regimen with 6-propylthiouracil, chloroquine phosphate and 5-fluorouracil (which resulted in 77% and 65% complete mouse tumor remission), may be effective in treating AIDS and other retrovirus-caused diseases.

Acquired Immunodeficiency Syndrome↗

Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate.

In two separate experiments, treatment of C3H/He mice bearing transplantable mammary adenocarcinomas (C3HBA) with a regimen of 6-propylthiouracil (PTUra) and 5-fluorouracil (FUra) plus chloroquine phosphate (CP) resulted in complete remissions of 77 and 65%, respectively. Treatment with PTUra alone resulted in 41% remissions in experiment 1 and 35% remissions in experiment 2. None of the nontreated control mice in either experiment had spontaneous remissions, and all controls died in each experiment. The principal effect was apparently due to the treatment with PTUra, inasmuch as most of the tumors disappeared during the 21-day treatment period. This observation indicated that the proper timing of the thyroid treatment with PTUra was crucial to achieve the best results. The combined FUra+CP regimen augmented the effects of the thyroid treatment and resulted in an increase in remissions.

Adenocarcinoma↗

Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.

Injection of 5-fluorouracil (5-FUra) [12 mg/kg i.p. (0.1 ml) every other day] and chloroquine phosphate (CP) [10 mg/kg i.p. (0.1 ml) daily] after the 19th day postimplant brought about a 55% complete remission of mammary carcinoma (C3HBA) in 2 separate experiments. FUra used alone brought about 40% complete tumor remissions, whereas CP used alone resulted in 30% complete remissions. None of these tumors reappeared before 189 days postimplant in Experiment 1 and 120 days postimplant in Experiment 2. The 5-FUra + CP treatment showed statistically (P less than 0.05) smaller tumor sizes compared to control mice tumor sizes on each of 13 check days after treatment was begun. The CP-treated tumors were statistically smaller than the control tumors on 10 check days, whereas the 5-FUra-treated tumors were smaller than the control tumors on 9 check days. The 5-FUra-treated tumors were statistically smaller than the CP-treated tumors on 2 check days (23 and 33). The 5-FUra + CP-treated tumors were statistically smaller than the CP-treated tumors on 3 check days (36, 43, and 47), and the 5-FUra + CP-treated tumors were statistically smaller than the 5-FUra-treated tumors on the last 4 check days (54, 57, 61, and 64).

Animals↗